Patent ductus arteriosus (PDA) is one of the most common congenital heart defects, and causes left ventricular volume overload. However, it is a rare finding among adults due to the lack of symptoms related to its small size, and it is not usually associated with other congenital lesions.
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A 53-year-old woman was referred for percutaneous closure of a PDA. She had undergone a secundum atrial septal defect (ASD) closure in 2007, detected after a cryptogenic stroke. After this procedure, her clinical history was remarkable for fatigue, dyspnea and orthopnea with New York Heart Association (NYHA) functional class III, and a continuous murmur was heard over the left sternal border. A routine transthoracic echocardiogram performed in 2013 revealed a continuous flow from the aorta towards the pulmonary artery, with left-sided chamber dilation (ejection fraction 50%) and normal pulmonary artery pressure. The device previously implanted at the atrial septum was correctly positioned and without residual shunt ( Figure 1) . The PDA was closed by placing an Amplatzer TM Duct Occluder guided by fluoroscopy and intracardiac echocardiography ( Figure 2 ). The procedure was uneventful. The 12-month follow-up showed significant clinical improvement (NYHA functional class II), no residual shunt, and normal left chamber dimensions ( Figure 3 ).
In this case, the association with an ASD may have delayed the clinical manifestations of the PDA, as the previous left-to-right shunt probably compensated for the left ventricular volume overload. It is crucial to perform a complete high-quality echocardiogram in such patients with congenital heart disease, in order to screen for associated anomalies.
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Figure 2
Fluoroscopy during percutaneous patent ductus arteriosus closure: left, a continuous flow can be seen from the aorta to the pulmonary artery (yellow arrow); center, during device placement (yellow arrow); right, after the procedure the device is properly positioned with no residual shunt (yellow arrow). 
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